Median Technologies SA Sustainability Reports
The company develops and markets AI-powered software medical devices and advanced imaging services for oncology clinical trials and early cancer diagnosis. It helps biopharmaceutical companies and clinicians analyze medical images to advance patient care and accelerate oncology drug development.
Sector: Business support services
Country: France
Exchange: Euronext Paris
LEI: 9695007YG6O07A8N6395
FIGI: BBG001V1CLY3
7 reports from 2013 to 2025
